Your session is about to expire
← Back to Search
Dog Walking for Post Intensive Care Syndrome (POOCH Trial)
N/A
Recruiting
Led By Lindsey Nelson, MSN, RN
Research Sponsored by University of Missouri, Kansas City
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up feasibility data will be collected and analyzed from the time identifying, screening, and recruiting eligible participants begins to the time the final participant completes the study; no more than 12 months.
Awards & highlights
POOCH Trial Summary
This trial will compare the effects of a pet dog-walking intervention to an attention control education intervention on depression, anxiety, cortisol, and quality of life of adult ICU survivors.
Who is the study for?
This trial is for adults over 18 who survived an ICU stay, can walk their own dog, and have mild depression or anxiety. They must speak English, live within 30 miles of the hospital, and not be at high risk for suicide or have severe mental health issues.Check my eligibility
What is being tested?
The study compares a group walking their dogs three times a week with those reading about dog health to see effects on mood, stress hormone levels (cortisol), and life satisfaction in ICU survivors.See study design
What are the potential side effects?
There are no direct medical side effects from participating in this trial as it involves non-medical interventions like dog walking and reading educational materials.
POOCH Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ feasibility data will be collected and analyzed from the time identifying, screening, and recruiting eligible participants begins to the time the final participant completes the study; no more than 12 months.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~feasibility data will be collected and analyzed from the time identifying, screening, and recruiting eligible participants begins to the time the final participant completes the study; no more than 12 months.
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Study Acceptability as assessed by participant responses to survey questions regarding the amount of time spent in the study, the measurement tools used, the masking procedure, and the intervention.
Study Feasibility as assessed by recruitment results, attrition rates, intervention fidelity, and missing data points
Secondary outcome measures
Change in Anxiety
Change in Depression
Change in Quality of Life as assessed by health related quality of life indicators including physical functioning, physical and emotional limitations, social functioning, bodily pain, general and mental health.
+1 morePOOCH Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention GroupExperimental Treatment1 Intervention
Companion dog walking
Group II: Attention Control GroupActive Control1 Intervention
Educational resources about dog health
Find a Location
Who is running the clinical trial?
SIGMA International Honor Society of NursingUNKNOWN
University of Missouri, Kansas CityLead Sponsor
69 Previous Clinical Trials
32,614 Total Patients Enrolled
Sigma Theta Tau International Honor Society of NursingOTHER
9 Previous Clinical Trials
371 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I can walk a dog.I recently started treatment for depression or anxiety.I experience symptoms of depression or anxiety.Walking my dog is considered unsafe for both of us.I am 18 years old or older.I walk my dog for less than 10 minutes a week.I can stand up, walk, and sit down again in 20 seconds or less.
Research Study Groups:
This trial has the following groups:- Group 1: Intervention Group
- Group 2: Attention Control Group
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is there currently an intake of participants for this trial?
"As documented on clinicaltrials.gov, the recruiting window for this particular medical trial has closed; it was first posted in June of 2023 and last updated April 18th of that same year. Nonetheless, there are presently 1,615 other trials seeking participants at this time."
Answered by AI
What aims is this research endeavor attempting to achieve?
"The primary objective of this medical trial is to measure Acceptability, as determined by participant surveys concerning the duration of study participation, instruments used for data collection and masking techniques. Secondary outcomes include Change in Anxiety (as assessed through Spielberger State Trait Anxiety Inventory), Quality of Life (Short Form 36 questionnaire) and Serum Cortisol levels (obtained via peripheral venous blood sample). Feasibility will be evaluated from patient recruitment until final completion; no more than 12 months."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger